Elon Musk has officially departed from the Trump administration as his term as a “special government employee” concluded after 130 days. This development follows media reports alleging Musk’s frequent drug use during his campaigning with Trump in 2024, including substances like ketamine, ecstasy, and psychedelic mushrooms. The New York Times cited unnamed sources to outline these claims, but it remains uncertain if Musk engaged in this behavior while working in the Department of Government Efficiency.
During a media briefing on May 30, President Trump addressed the allegations, expressing he was unaware of any drug use by Musk, whom he described as “fantastic.” When asked if he was concerned about the allegations, Trump stated, “I’m not troubled by anything with Elon.” On the same day, when a reporter attempted to question Musk regarding the drug accusations at an Oval Office event, Musk sidestepped the inquiry and criticized the New York Times for its coverage of Russian interference in the 2016 election, insisting, “Let’s move on.”
In addition to his roles as CEO of Tesla, SpaceX, and owner of the social media platform X, Musk had previously acknowledged in March 2024 that he used prescription ketamine to manage depression. This acknowledgment followed past controversies, including an incident in 2018 where he smoked marijuana during a podcast, raising concerns among corporate executives. As Musk steps away from the administration, the focus now shifts to the implications of his departure and the ongoing discussions surrounding his personal life and public persona.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
